Table 1.
Biomarker | Source | Detection method | Deregulation | Function | Utility | Source | Ref |
---|---|---|---|---|---|---|---|
cfDNA | serum | PCR reaction | upregulated | Unknown | ccRCC diagnosis | Coon JJ et al. | 36 |
cfDNA | plasma | real-time PCR | upregulated | Unknown | identification of metastatic ccRCC patients during the course of sorafenib therapy | Lee et al. | 37 |
cfDNA | plasma | real-time PCR | upregulated | Unknown | diagnosis and detection of recurrence after nephrectomy | Gang et al. | 38 |
miRNA-187 | serum | qPCR | downregulated | Unknown | ccRCC diagnosis | Zhao et al. | 44 |
miRNA 210 | serum | qPCR | upregulated | role in tumorigenesis | ccRCC detection | Camps et al. | 43 |
miR‑141 , | serum | qPCR | downregulated | Unknown | ccRCC diagnosis | Cheng et al. | 45 |
miR‑34a and miR‑21 miR‑224 | serum | qPCR | upregulated | Unknown | ccRCC diagnosis | Cheng et al. | 45 |
sIL-2R | serum | ELISA immunoassay | upregulated | activation of T cells and regulation immune response | ccRCC diagnosis and detection | Masuda et al. | 46 |
sB7-H3 | serum | ELISA immunoassay | downregulated | inhibition of T cell activity | ccRCC diagnosis and detection | Masuda et al. | 46 |
proteasome 20S | serum | sandwich enzyme-linked immunosorbent assay | downregulated | protein degradation | ccRCC diagnosis and prognosis | De Martino et al. | 54 |
zinc finger proteins | serum | matrix-assisted laser desorption ionization (MALDI) TOF) mass spectrometry (MS) | upregulated | includes a motif which mediates biding to molecules such as protein, DNA and RNA. | ccRCC detection | Yang et al. | 55 |
RNA-binding proteins (RBPs) | serum | MALDI TOF MS | upregulated | binds to RNA molecules and plays significant role in forming ribonucleoproteins splicing of mRNA, polyadenylation, stabilization, localization and translation | ccRCC detection | Yang et al. | 55 |
protein TUBB | serum | MALDI TOF MS | upregulated | consisting of microtubules | ccRCC detection | Yang et al. | 55 |
B7x | serum | ELISA immunoassay | upregulated | downregulation of peripheral immune responses via negative T-cell costimulation | ccRCC diagnosis and detection | Krambeck et al. | 49 |
collagen fragments below 1.4 kDa | urine | capillary electrophoresis coupled to mass spectrometry (CE-MS) | downregulated | activation of platelet response, involvement in thrombosis and hemostasis engagement in replacement and restoration of dead skin cells | ccRCC diagnosis and prognosis | Chinello et al. | 57 |
peptides from inflammatory and immune proteins | urine | CE-MS | downregulated | Unknown | ccRCC diagnosis and prognosis | Frantzi et al. | 51 |
peptides involved in coagulation and platelet aggregation | urine | CE-MS | upregulated | Unknown | ccRCC diagnosis and prognosis | Frantzi et al. | 51 |
fragments of the human glycoprotein uromodulin (UMOD/THP) | urine | MALDI TOF MS | upregulated | regulatory protein, prevention of urinary tract from infections and injuries caused by products from tubular fluids. Protection against calcium oxalate crystal formation | ccRCC diagnosis and prognosis | Chinello et al. | 57 |
fragment of fibrinogen alpha chain (FIBA) |
urine | MALDI TOF MS | upregulated | involvement in hemostasis, platelet aggregation and wound repair | ccRCC diagnosis and prognosis | Frantzi et al. | 51 |